Werewolf Therapeutics Inc...

NASDAQ: HOWL · Real-Time Price · USD
1.35
0.03 (2.27%)
At close: Aug 15, 2025, 2:21 PM

Werewolf Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-70.52M -37.37M -53.81M -49.98M
Depreciation & Amortization
1.81M 1.76M 1.1M 216K
Stock-Based Compensation
8.83M 8.01M 7.4M 4.09M
Other Working Capital
-2.28M -7.14M 3.42M 1.27M
Other Non-Cash Items
1.16M 878K 2.17M 519K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
2.53M -5.89M 2.54M 2.28M
Operating Cash Flow
-56.19M -32.61M -40.6M -42.88M
Capital Expenditures
-254K -769K -3.61M -498K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-254K -769K -3.61M -498K
Debt Repayment
-10M 40M n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-496K 100K 166K -2.17M
Financial Cash Flow
13.08M 58.43M 15.91M 109.43M
Net Cash Flow
-43.36M 25.05M -28.3M 66.05M
Free Cash Flow
-56.44M -33.38M -44.21M -43.37M